Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide

[1]  Y. Kaneda,et al.  Fusigenic viral liposome for gene therapy in cardiovascular diseases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Y. Yazaki,et al.  Nonmuscle and smooth muscle myosin heavy chain expression in rejected cardiac allografts. A study in rat and monkey models. , 1996, Circulation.

[3]  P. Linsley,et al.  Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways , 1996, Nature.

[4]  A. Matsumori,et al.  Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril. , 1996, Circulation.

[5]  Y. Kaneda,et al.  Efficiency of in vivo gene transfection into transplanted rat heart by coronary infusion of HVJ liposome. , 1995, Circulation.

[6]  A. Yeung,et al.  Influence of preexistent donor coronary artery disease on the progression of transplant vasculopathy. An intravascular ultrasound study. , 1995, Circulation.

[7]  R. Novick,et al.  The Registry of the International Society for Heart and Lung Transplantation: twelfth official report--1995. , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  G. Nuovo,et al.  In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. , 1994, The American journal of pathology.

[9]  T. Ogihara,et al.  Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. , 1994, The Journal of clinical investigation.

[10]  J. Hosenpud,et al.  Immune mechanisms of cardiac allograft vasculopathy: an update. , 1993, Transplant immunology.

[11]  T. Ogihara,et al.  Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Fabrega,et al.  Diltiazem in the prevention of coronary artery disease in heart-transplant recipients. , 1993, The New England journal of medicine.

[13]  James M. Roberts,et al.  Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. , 1993, Science.

[14]  A. Wechsler,et al.  Inhibition of Accelerated Coronary Atherosclerosis With Dehydroepiandrosterone in the Heterotopic Rabbit Model of Cardiac Transplantation , 1993, Circulation.

[15]  M. Isobe,et al.  Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. , 1992, Science.

[16]  M. Pagano,et al.  Association of cdk2 kinase with the transcription factor E2F during S phase. , 1992, Science.

[17]  M. Meyerson,et al.  Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase , 1991, Nature.

[18]  M. Cybulsky,et al.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.

[19]  K. Iwai,et al.  Increased expression of DNA cointroduced with nuclear protein in adult rat liver. , 1989, Science.